Frank Tufaro

Directeur Général chez DNAtrix, Inc.

Profil

Frank Tufaro is the founder of Medigene, Inc., Nurel Therapeutics, Inc., NeuroVir Therapeutic, Inc. He is currently the Chief Executive Officer & Director at DNAtrix, Inc. and a Director at Protocol Intelligence, Inc. Previously, he served as the Chief Executive Officer of Allera Health Products, Inc. and held the position of President, Chief Executive Officer & Director at DNAtrix, Inc. from 2010 to 2019.
He was also a Professor of Microbiology & Immunology at the University of British Columbia from 1987 to 2002.
Additionally, he worked as the Chief Operating Officer at Theriva Biologics SL.
In 2020, he served as the President of Opa Therapeutics, Inc. and in 2022, he became the Chief Operating Officer at Theriva Biologics, Inc. Dr. Tufaro obtained his undergraduate and doctorate degrees from McGill University.

Postes actifs de Frank Tufaro

Sociétés	Poste	Début
Protocol Intelligence, Inc.	Directeur/Membre du Conseil	-
DNAtrix, Inc.	Directeur Général	-

Anciens postes connus de Frank Tufaro

Sociétés	Poste	Fin
THERIVA BIOLOGICS, INC.	Directeur des opérations	10/05/2023
Opa Therapeutics, Inc.	President	01/03/2022
DNAtrix, Inc.	Directeur Général	01/12/2019
University of British Columbia	Corporate Officer/Principal	01/01/2002
Theriva Biologics SL	Directeur des opérations	-